Literature DB >> 30571168

Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.

Jeremy D Furtado1, Rain Yamamoto1,2, John T Melchior3, Allison B Andraski1, Maria Gamez-Guerrero1,4, Patrick Mulcahy1,5, Zeling He6, Tianxi Cai6, W Sean Davidson3, Frank M Sacks1.   

Abstract

Objective- HDL (high-density lipoprotein) in plasma is a heterogeneous group of lipoproteins typically containing apo AI as the principal protein. Most HDLs contain additional proteins from a palate of nearly 100 HDL-associated polypeptides. We hypothesized that some of these proteins define distinct and stable apo AI HDL subspecies with unique proteomes that drive function and associations with disease. Approach and Results- We produced 17 plasma pools from 80 normolipidemic human participants (32 men, 48 women; aged 21-66 years). Using immunoaffinity isolation techniques, we isolated apo AI containing species from plasma and then used antibodies to 16 additional HDL protein components to isolate compositional subspecies. We characterized previously described HDL subspecies containing apo AII, apo CIII, and apo E; and 13 novel HDL subspecies defined by presence of apo AIV, apo CI, apo CII, apo J, α-1-antitrypsin, α-2-macroglobulin, plasminogen, fibrinogen, ceruloplasmin, haptoglobin, paraoxonase-1, apo LI, or complement C3. The novel species ranged in abundance from 1% to 18% of total plasma apo AI. Their concentrations were stable over time as demonstrated by intraclass correlations in repeated sampling from the same participants over 3 to 24 months (0.33-0.86; mean 0.62). Some proteomes of the subspecies relative to total HDL were strongly correlated, often among subspecies defined by similar functions: lipid metabolism, hemostasis, antioxidant, or anti-inflammatory. Permutation analysis showed that the proteomes of 12 of the 16 subspecies differed significantly from that of total HDL. Conclusions- Taken together, correlation and permutation analyses support speciation of HDL. Functional studies of these novel subspecies and determination of their relation to diseases may provide new avenues to understand the HDL system of lipoproteins.

Entities:  

Keywords:  apolipoproteins; cardiovascular diseases; enzyme-linked immunosorbent assay; humans; lipoproteins, HDL; peptides; proteomics

Mesh:

Substances:

Year:  2018        PMID: 30571168      PMCID: PMC6309805          DOI: 10.1161/ATVBAHA.118.311607

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  60 in total

1.  Serum amyloid A impairs the antiinflammatory properties of HDL.

Authors:  Chang Yeop Han; Chongren Tang; Myriam E Guevara; Hao Wei; Tomasz Wietecha; Baohai Shao; Savitha Subramanian; Mohamed Omer; Shari Wang; Kevin D O'Brien; Santica M Marcovina; Thomas N Wight; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; William R Osborne; Keith B Elkon; Alan Chait
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

2.  Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins.

Authors:  Manfred Heller; Daniel Stalder; Evelyn Schlappritzi; Gertraud Hayn; Urs Matter; André Haeberli
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

3.  Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

Authors:  Louise Bowman; Jemma C Hopewell; Fang Chen; Karl Wallendszus; William Stevens; Rory Collins; Stephen D Wiviott; Christopher P Cannon; Eugene Braunwald; Emily Sammons; Martin J Landray
Journal:  N Engl J Med       Date:  2017-08-28       Impact factor: 91.245

4.  Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies.

Authors:  Scott M Gordon; Jingyuan Deng; Alex B Tomann; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  Mol Cell Proteomics       Date:  2013-07-23       Impact factor: 5.911

5.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

6.  In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.

Authors:  D J Rader; G Castro; L A Zech; J C Fruchart; H B Brewer
Journal:  J Lipid Res       Date:  1991-11       Impact factor: 5.922

7.  Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum.

Authors:  Benoit Vanhollebeke; Marianne J Nielsen; Yoshihisa Watanabe; Philippe Truc; Luc Vanhamme; Kazunori Nakajima; Soren K Moestrup; Etienne Pays
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

8.  Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.

Authors:  Stephen Zewinger; Christiane Drechsler; Marcus E Kleber; Alexander Dressel; Julia Riffel; Sarah Triem; Marlene Lehmann; Chantal Kopecky; Marcus D Säemann; Philipp M Lepper; Günther Silbernagel; Hubert Scharnagl; Andreas Ritsch; Barbara Thorand; Tonia de las Heras Gala; Stefan Wagenpfeil; Wolfgang Koenig; Annette Peters; Ulrich Laufs; Christoph Wanner; Danilo Fliser; Thimoteus Speer; Winfried März
Journal:  Eur Heart J       Date:  2015-08-06       Impact factor: 29.983

9.  Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients.

Authors:  Jing Yan Mao; Jia Teng Sun; Ke Yang; Wei Feng Shen; Lin Lu; Rui Yan Zhang; Xuemei Tong; Yan Liu
Journal:  J Diabetes Complications       Date:  2017-07-13       Impact factor: 2.852

Review 10.  Activity of trypanosome lytic factor: a novel component of innate immunity.

Authors:  Russell Thomson; Marie Samanovic; Jayne Raper
Journal:  Future Microbiol       Date:  2009-09       Impact factor: 3.165

View more
  31 in total

1.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

2.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

3.  Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.

Authors:  Yunosuke Matsuura; Jenny E Kanter; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

4.  Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men.

Authors:  Leah E Cahill; Frank M Sacks; Eric B Rimm; Majken K Jensen
Journal:  J Lipid Res       Date:  2019-05-29       Impact factor: 5.922

5.  Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.

Authors:  Frank M Sacks; Liang Liang; Jeremy D Furtado; Tianxi Cai; W Sean Davidson; Zeling He; Robyn L McClelland; Eric B Rimm; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-10       Impact factor: 8.311

Review 6.  HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.

Authors:  C R Sirtori; M Ruscica; L Calabresi; G Chiesa; R Giovannoni; J J Badimon
Journal:  Ann Med       Date:  2019 Nov - Dec       Impact factor: 4.709

Review 7.  Deepening our understanding of HDL proteome.

Authors:  Graziella Eliza Ronsein; Tomáš Vaisar
Journal:  Expert Rev Proteomics       Date:  2019-08-27       Impact factor: 3.940

8.  Lipid mass spectrometry imaging and proteomic analysis of severe aortic stenosis.

Authors:  Jihyeon Lim; Jennifer T Aguilan; Rani S Sellers; Fnu Nagajyothi; Louis M Weiss; Ruth Hogue Angeletti; Anna E Bortnick
Journal:  J Mol Histol       Date:  2020-08-13       Impact factor: 2.611

9.  High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia.

Authors:  Manja Koch; Steven T DeKosky; Matthew Goodman; Jiehuan Sun; Jeremy D Furtado; Annette L Fitzpatrick; Rachel H Mackey; Tianxi Cai; Oscar L Lopez; Lewis H Kuller; Kenneth J Mukamal; Majken K Jensen
Journal:  J Lipid Res       Date:  2019-12-31       Impact factor: 5.922

10.  Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis.

Authors:  Kjetil Bjornevik; Éilis J O'Reilly; Marianna Cortese; Jeremy D Furtado; Laurence N Kolonel; Loic Le Marchand; Marjorie L Mccullough; Sabrina Paganoni; Michael A Schwarzschild; Aladdin H Shadyab; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-09-28       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.